This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.
A Phase IV Study of Safety and Efficacy of Everolimus in Taiwanese Patients With Tuberous Sclerosis Complex Who Have Renal Angiomyolipoma (TSC-AML) | MicrobiomeTrials
← Back to trials NCT05252585
A Phase IV Study of Safety and Efficacy of Everolimus in Taiwanese Patients With Tuberous Sclerosis Complex Who Have Renal Angiomyolipoma (TSC-AML) Recruiting PHASE4 INTERVENTIONAL
Read the full scientific description See full eligibility requirements Trial Details Start: 2023-05-01Est. Completion: 2026-10-10
Enrollment target: 4 participantsLocations Novartis Investigative Site, Taichung, Taiwan ROC, Taiwan Novartis Investigative Site, Taoyuan, Taiwan ROC, Taiwan Novartis Investigative Site, Taipei, Taiwan Novartis Investigative Site, Taoyuan, Taiwan Other microbiome trials you might be interested in Renal Cell Carcinoma (RCC)
Multi-center, single arm, prospective trial to estimate safety, feasibility, technical outcomes, and clinical outcomes o…
Birmingham, United States Completed Nov 19, 2025
Renal Angiomyolipomas Tuberous Sclerosis
Treatment of angiomyolipomas is based on invasive techniques such as surgery or embolization. Development of anti-angiog…
Bordeaux, France Completed Nov 22, 2017